Would you like to receive important updates about DaVita HealthCare Partners Inc like earnings dates and more?
The Year To Date (YTD) return is +1.53%.
The 52 Week Low stock price is 52.51 set on Wed, Nov 8, 2017 which is 102 days ago.
The current price per share is 40.26% above the 52 week low.
The 52 Week High stock price is $80.71 set on Thu, Jan 11, 2018 which is 38 days ago.
The current price per share is -8.75% below the 52 week high.
The All Time High stock price is $85.17 set on Mon, Apr 27, 2015 which is 1,028 days ago.
The current price per share is -13.53% below the all time high.
The DaVita HealthCare 5 year stock chart shows the historical prices over the previous 60 months.
The DaVita HealthCare 1 year stock chart shows the historical prices over the previous 12 months.
The 50 Day Moving Average is at $61.00 which is 20.74% below the stock price of $73.65.
The 200 Day Moving Average is at 64.66 which is 13.90% below the stock price of $73.65.
Because both the 50 DMA and 200 DMA are below the current stock price, this can be considered a bullish technical indicator.
Since the stock price is very far from both moving averages, a price retracement towards the moving averages should not be unexpected.
DaVita HealthCare Partners Inc is a Health Care stock that trades on the NYSE and has a market capitalization of $13.61 Billion.
DaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. Its DMG division is a patient- and physician-focused integrated healthcare delivery and management company that provides medical services to members through capitation contracts. Its segments include U.S. dialysis and related lab services, DMG, and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2016, it had operated or provided administrative services to 154 outpatient dialysis centers.
For more information and analysis about DaVita HealthCare Partners Inc, visit their web site at http://www.davita.com. For a real time price lookup on this ticker, DVA, visit Google Finance and Bloomberg.
Below are several other Health Care Facilities & Services stocks include AmerisourceBergen Corp (ABC), Aetna Inc (AET), Anthem Inc (ANTM), Cardinal Health Inc (CAH), Cigna Corp (CI), Centene Corp (CNC), Quest Diagnostics Inc (DGX), DaVita HealthCare Partners Inc (DVA), Express Scripts Holding Co (ESRX), HCA Holdings Inc (HCA), .
The EPS is $4.85.
The P/E Ratio is 15.31%.
DaVita HealthCare has a relatively low price to earnings ratio compared to the overal S&P 500 average, which is about 25%.
Some investors look for very low p/e stocks with the hopes of investing in an undervalued stock. Of course, this is just one factor to consider.
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for DaVita HealthCare Partners Inc was Tue, Nov 7, 2017.
Since this earnings release 103 days ago, the stock price is up by +23.97%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The most recent Earnings Release Date was on Tue, Feb 13, 2018, which was 5 days ago.
Since this earnings date, the stock price is up by +0.33%.
DVA currently does not pay a dividend.
You may like this list of best dividend stocks of 2018.